Coronavirus Vaccine? Two Pharmaceutical Giants Collaborating To Develop One
Pharmaceutical companies GSK and Sanofi are partnering to work on several vaccine candidates to fight the coronavirus.
Pharmaceuticals
FDA OK's Addition To Stockpile Of Malaria Drugs For COVID-19
Chloroquine and hydroxycloroquine got the Food and Drug Administration's go-ahead to be put in the nation's strategic storehouses. But the drugs haven't been approved to treat coronavirus patients.
FDA Grants Experimental Coronavirus Drug Benefits For Rare Disease Treatments
Gilead Science's remdesivir, an antiviral medicine being tested for treatment of COVID-19, would get a seven-year monopoly if approved by the Food and Drug Administration.
Insurers Cover Fewer Drugs, Leaving Some Patients Struggling To Get Needed Treatments
A new report finds insurers are becoming more selective about which medications they'll cover. Patients and doctors have to work harder to get treatments approved.
How Coronavirus Is Affecting The U.S. Pharmaceutical Supply
In China, drug manufacturers are getting back to work. But supply chain disruptions could still lead to drug shortages down the road.
Hormone Blocker Sticker Shock: Kids Drug Costs 8 Times More Than One For Adults
Two nearly identical drug implants have very different prices. The one for kids has a list price of $37,300. For adults, it's $4,400. A dad fought for his daughter to be able to get the cheaper drug.
When Insurance Won't Cover Drugs, Americans Make 'Tough Choices' About Their Health
With drug costs on the rise — and insurers refusing to cover some prescriptions — even patients with insurance can find themselves facing high out-of-pocket costs or going without.
FDA Approves Drugs Faster Than Ever But Relies On Weaker Evidence, Researchers Find
Changes in the way the Food and Drug Administration reviews new medicines means that there are more cures and treatments on the market. But there's also less proof the drugs are safe and effective.
A Decade Marked By Outrage Over Drug Prices
Nearly 1 in 4 Americans has trouble affording prescription drugs, according to a Kaiser Family Foundation poll. Over the past decade, high prices of several medicines have become flashpoints.
A Cancer Drug For Parkinson's? New Study Raises Hope, Draws Criticism
A leukemia drug seemed to help patients with Parkinson's disease. But critics say the results are equivocal and could raise false hopes.